Analyst consensus rating
Disc Medicine Analyst Rating: Strong Buy
Direct answer
Disc Medicine's consensus rating is Strong Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $102.58.
Forecast evidence checked September 12, 2026.
Get free Disc Medicine email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $70.06
- Average price target
- $102.58
- High price target
- $128.00
- Low price target
- $79.00
- Low target gap
- +12.8%
- Target upside
- +46.4%
- High target gap
- +82.7%
- Target range width
- 69.9%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- September 12, 2026
- Valid through
- September 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Disc Medicine?
Disc Medicine has a verified Strong Buy consensus. The same dataset has an average price target of $102.58.
How far are Disc Medicine's low and high targets from the recorded price?
The low target implies +12.8%, while the high target implies +82.7%.
How many analysts are included in Disc Medicine's consensus?
The verified consensus includes 12 analysts.
How is Disc Medicine's target upside or downside calculated?
The average target of $102.58 is divided by the recorded price of $70.06, then one is subtracted to produce +46.4%. This does not guarantee a future return.
When was Disc Medicine's analyst forecast verified?
The data was verified on 2026-09-12. The dataset is valid through 2026-09-19.